LAT1 inhibition by JPH203 treatment has been reported to suppress mTOR in cancer cells [12, 13, 15], and targeting LAT1 have been suggested to be synergized with rapamycin for cancer therapy [12]. This evidence concerns the gene SLC7A5 and cancer.